1. Home
  2. CPF vs RGNX Comparison

CPF vs RGNX Comparison

Compare CPF & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Pacific Financial Corp New

CPF

Central Pacific Financial Corp New

HOLD

Current Price

$37.87

Market Cap

916.6M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$6.57

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPF
RGNX
Founded
1954
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
916.6M
793.5M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
CPF
RGNX
Price
$37.87
$6.57
Analyst Decision
Buy
Buy
Analyst Count
5
12
Target Price
★ $41.75
$23.58
AVG Volume (30 Days)
125.1K
★ 1.3M
Earning Date
10-28-2026
11-09-2026
Dividend Yield
★ 3.18%
N/A
EPS Growth
★ 45.18
18.08
EPS
★ 1.58
N/A
Revenue
★ $51,817,000.00
$10,393,000.00
Revenue This Year
$4.16
N/A
Revenue Next Year
$3.45
$23.50
P/E Ratio
$23.92
★ N/A
Revenue Growth
33.81
★ 126.48
52 Week Low
$28.10
$5.46
52 Week High
$40.99
$16.19

Technical Indicators

Market Signals
Indicator
CPF
RGNX
Relative Strength Index (RSI) 63.46 34.87
Support Level $36.91 $5.67
Resistance Level $38.34 $7.32
Average True Range (ATR) 0.65 0.46
MACD 0.29 -0.01
Stochastic Oscillator 90.20 2.73

Price Performance

Historical Comparison
CPF
RGNX

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: